Abstract
Background: The aim of this study was to investigate the efficacy of concentrated growth factor (CGF) in type 1 tympanoplasty. Methods: This study represents a retrospective analysis of a non-randomized interventional cohort study, included 60 patients who underwent primary type 1 tympanoplasty between November 2024 and July 2025. The patients were divided into those who received only a cartilage graft ( n = 30) and those who received a cartilage graft and CGF ( n = 30). The incidence rates of residual tympanic membrane perforation, audiological outcomes, and postoperative infection rates were compared. Results: The incidence rate of residual perforation was significantly lower in the CGF group than in the cartilage-only group. The audiological outcomes showed no significant differences between the groups. Postoperative infection was observed less frequently in the CGF group. Conclusion: CGF may represent a promising adjunct in type 1 tympanoplasty by potentially supporting graft integration and reducing residual perforation rates.
Funding Information
  • University of Health Sciences

This publication has 15 references indexed in Scilit: